Date Hour Room Track
05th December,2018 11:00 am-12:30 pm Track 1

What are the consequences and benefits of adding patient organisations to existing alliances? How do these collaborations work? How do they create value for the whole life sciences community? What is the actual influence on patients of public/private partnerships? What is the actual involvement of patient organisation in financing the collaborations?

Andreas L.G. Reimann - ADMEDICUM Business for Patients
Bernd Stowasser - Sanofi
Mathias Schmidt - ArmaGen, Inc
Olivier Arnaud - JDRF - Juvenile Diabetes Research Foundation

Continue your tour